[Metabolic diseases--a new challenge for pediatric intensive care].
Reichel
Annette
A
Kinderintensivstation, Universitätsklinikum Hamburg-Eppendorf, Hamburg.
George
Mathias
M
D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D002648:Child; D003241:Consanguinity; D003937:Diagnosis, Differential; D004041:Dietary Fats / Q000008:administration & dosage / Q000378:metabolism; D018450:Disease Progression; D004734:Energy Metabolism / Q000235:genetics; D004827:Epilepsy / Q000188:drug therapy / Q000235:genetics / Q000451:nursing; D017809:Fatal Outcome; D005260:Female; D051272:Glucose Transporter Type 1; D006801:Humans; D015278:Intensive Care Units, Pediatric; D007657:Ketone Bodies / Q000097:blood; D008659:Metabolic Diseases / Q000235:genetics / Q000451:nursing*; D009004:Monosaccharide Transport Proteins / Q000235:genetics; D009733:Nursing Diagnosis; D018458:Persistent Vegetative State / Q000235:genetics / Q000451:nursing*; D015325:Pyruvate Dehydrogenase Complex Deficiency Disease / Q000235:genetics
D000927:Anticonvulsants; D004041:Dietary Fats; D051272:Glucose Transporter Type 1; D007657:Ketone Bodies; D009004:Monosaccharide Transport Proteins; C495677:SLC2A1 protein, human